- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03938688
Randomized Control Trial Comparing Transfascial Suture for Mesh Fixation to No Mesh Fixation
Two-armed Single Blinded Non-inferiority Registry Based Randomized Control Trial Comparing Transfascial Sutures for Mesh Fixation to No Mesh Fixation for Open Retromuscular Repairs
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The techniques of mesh fixation in open incisional hernia repair is an active area of discussion and debate. When first described, the posterior component separation with the transversus abdominis muscle release involved placing the mesh in the retromuscular space, and fixating it circumferentially with transfascial sutures. These sutures penetrate the entire length of the abdominal wall and can be a significant source of pain. This study aims to evaluate the effect of using no fixation on recurrence rates, compared to the standard of care of using transfacial sutures. The investigators hypothesize that recurrences rates for patients who receive no fixation will be non-inferior to those receiving transfascial sutures.
This will be a single blinded, registry based, non-inferiority, randomized control trial comparing transfacial sutures for mesh fixation to no mesh fixation in open retromuscular repairs. This will be a two-arm trial with intervention 1: intervention 2 and control allocation ratio of 1:1. The Americas Hernia Society Quality Collaborative (AHSQC) will serve as the platform for data collection. The AHSQC is a multicenter, nationwide quality improvement effort with the mission of improving the quality of hernia care. Data points not recorded in the AHSQC will be collected by a trained research coordination or research fellow and uploaded into a Research Electronic Data Capture (RedCAP®) database hosted at the Cleveland Clinic
Study population will include all adult patients (≥ 18 years) undergoing elective open ventral hernia repair, where the midline fascia can be approximated and mesh will be placed in the retromuscular position. Only a midline approach to hernia repair and hernia widths equal to or less than 20cm measured intraoperatively will be included. Exclusion criteria include patients unable to give consent, vulnerable populations, parastomal hernias, hernia width measuring more than 20cm intraoperatively, patients planned for minimally invasive approaches or open repairs with mesh placed in a position other than retromuscular, or those who were not able to undergo successful retromuscular mesh placement. Finally, open repairs performed through a different incision than the standard midline approach will also be considered exclusion criteria, as well as the inability to close the midline fascia.
Study Interventions:
- Intervention 1 (Control): Mesh will be placed in the retromuscular space, with wide overlap on all sides. Full thickness transfascial sutures will be placed circumferentially to secure the mesh using slowly absorbable no. 1 sutures. A total of six transfascial sutures will be placed universally for all patients with additional sutures allowed according to each surgeon's discretion. Additional bone or ligament sutures for mesh fixation will be allowed according to each surgeon's discretion.
- Intervention 2: Mesh will be placed in the retromuscular space, with wide overlap on all sides. No fixation method will be used. Bone or ligament sutures for mesh fixation will not be allowed.
Specific Aims:
- Aim 1: To investigate the non-inferiority of recurrence rates in patients receiving no fixation for a mesh placed in retromuscular position compared to those receiving circumferential transfascial suture fixation. Either physical examination, CT scan, or the Ventral Hernia Recurrence Inventory (VHRI) will be used to measure recurrence at one-year follow up.
- Aim 2: To determine if no mesh fixation results in less pain in the immediate postoperative period, measured by the Numeric Pain Rating Scale (NRS-11).
- Aim 3: To determine if no mesh fixation results in less pain on 30 day follow up, measured by using the Patient Reported Outcome Measurement Information System (PROMIS) Pain Intensity 3a survey
- Aim 4: To determine if in-hospital intravenous and oral opioid consumption will differ between those who received transfascial sutures and those who did not receive any fixation.
- Aim 5: To determine if length of stay will differ between those who received transfascial sutures and those who did not receive any fixation.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ohio
-
Cleveland, Ohio, United States, 44195
- Cleveland Clinic Center for Abdominal Core Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Undergoing elective open ventral hernia repair, where the midline fascia can be approximated and mesh will be placed in the retromuscular position
- A midline approach to hernia repair
- Hernia widths equal to or less than 20cm measured intraoperatively
Exclusion Criteria:
- Patients unable to give consent and vulnerable populations.
- Parastomal hernias
- Hernia width measuring more than 20cm intraoperatively
- Patients planned for minimally invasive approaches or open repairs with mesh placed in a position other than retromuscular, or those who were not able to undergo successful retromuscular mesh placement.
- Open repairs performed through a different incision than the standard midline approach
- Inability to close the midline fascia.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Transfascial sutures for mesh fixation
Mesh will be placed in the retromuscular space, with wide overlap on all sides.
Full thickness transfascial sutures will be placed circumferentially to secure the mesh using slowly absorbable no. 1 sutures.
A total of at least six transfascial sutures will be placed universally for all patients with additional sutures allowed according to each surgeon's discretion.
Additional bone or ligament sutures for mesh fixation will be allowed according to each surgeon's discretion.
|
Sutures that pass through the full thickness of the abdominal wall, which are used routinely for mesh fixation
|
No Intervention: No mesh fixation
Mesh will be placed in the retromuscular space, with wide overlap on all sides.
No fixation method will be used.
Bone or ligament sutures for mesh fixation will not be allowed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Recurrence
Time Frame: One year
|
primary outcome of interest is recurrence measured one year postoperatively as per standard of care at the Cleveland Clinic Center for Abdominal Core Health.
Hence, recurrence will be measured using either physical examination, CT scan, or the Ventral Hernia Recurrence Inventory (VHRI), either during a physical or a virtual clinic visit and/or using the telephone.
The VHRI is a validated patient reported outcomes tool, a three-question survey that can be administered directly to patients without clinical interaction.
|
One year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-operative pain
Time Frame: Baseline and 30 day follow up. The 30-day follow up period will extend from 15 - 45 days postoperatively.
|
Pain scores will be measured by Patient Reported Outcome Measurement Information System (PROMIS) Pain Intensity 3a survey.
The PROMIS pain intensity 3a survery is a National Institute of Health-developed validated tool, which focuses on PROs of pain characteristics.
|
Baseline and 30 day follow up. The 30-day follow up period will extend from 15 - 45 days postoperatively.
|
Post-operative pain
Time Frame: Baseline, first 7 days post-operatively, and 30 day follow up. The 30-day follow up period will extend from 15 - 45 days postoperatively.
|
Pain scores will be measured using the Numeric Pain Rating Scale (NRS-11).
The NRS-11 is Likert scale where the patient mark their current pain on scale from 1 to 10.
|
Baseline, first 7 days post-operatively, and 30 day follow up. The 30-day follow up period will extend from 15 - 45 days postoperatively.
|
Daily opioid requirements
Time Frame: first 7 days of the post-operative period
|
Opioid requirements will be assessed by measuring the cumulative dose of opioids administered intravenously (infused through a patient-controlled analgesia device as well as the quantity of opioids administered intravenously as rescue, if needed) and the quantity of opioids administered through oral preparations.
The total dose of opioid consumption will be converted to morphine equivalence.
|
first 7 days of the post-operative period
|
Length of stay
Time Frame: From date of admission to hospital until the date of discharge from hospital, assessed up to 60 weeks
|
Length of in-hospital stay will be measured
|
From date of admission to hospital until the date of discharge from hospital, assessed up to 60 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Ajita S Prabhu, The Cleveland Clinic
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 19-333
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ventral Hernia
-
Varazdin General HospitalCompletedIncisional Ventral Hernia | Recurrent Ventral HerniaCroatia
-
Anne Arundel Health System Research InstituteMedtronic - MITGCompletedGrade I Ventral Hernia | Grade II Ventral HerniaUnited States
-
University Hospital, Strasbourg, FranceRecruitingVentral Hernia RepairFrance
-
Makassed General HospitalSuspended
-
Sofregen Medical, Inc.TerminatedVentral Hernia RepairUnited States
-
Zaza DemetrashviliRecruitingLarge Midline Ventral HerniaGeorgia
-
Hvidovre University HospitalUniversity of CopenhagenCompleted
-
Hvidovre University HospitalCopenhagen University Hospital at HerlevCompleted
-
Hospices Civils de LyonRecruiting
-
Medtronic - MITGCompletedVentral Incisional HerniaFrance
Clinical Trials on Mesh placement with Transfascial Sutures
-
The Cleveland ClinicRecruiting
-
Oulu University HospitalCentral Finland Hospital DistrictRecruitingRecurrence | Hiatal Hernia | Hiatal Hernia, Paraesophageal | Paraesophageal HerniaFinland
-
University Hospital, GhentMedriActive, not recruiting
-
Ospedale di Circolo - Fondazione MacchiUnknown
-
Medtronic - MITGSofradim ProductionCompletedPain | Ventral HerniaSwitzerland
-
University of Campania "Luigi Vanvitelli"CompletedIncisional Hernia
-
IHU StrasbourgRecruiting
-
Rambam Health Care CampusWithdrawn
-
Varazdin General HospitalCompletedIncisional Ventral Hernia | Recurrent Ventral HerniaCroatia
-
Austrian Hernia Study GroupTerminatedObesity | Incisional HerniaAustria